Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria
<p>Abstract</p> <p>Background</p> <p>Currently, population pharmacokinetic (PK) studies of anti-malarial drugs are designed primarily by the logistical and ethical constraints of taking blood samples from patients, and the statistical models that are fitted to the data...
Main Authors: | Lindegardh Niklas, Tarning Joel, Duffull Stephen B, Jamsen Kris M, White Nicholas J, Simpson Julie A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-07-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/10/1/181 |
Similar Items
-
Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2011) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria
by: Jamsen Kris M, et al.
Published: (2012-07-01) -
Optimal designs for population pharmacokinetic studies of the partner drugs co-administered with artemisinin derivatives in patients with uncomplicated falciparum malaria.
by: Jamsen, K, et al.
Published: (2012) -
Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria.
by: Luxemburger, C, et al.
Published: (1995) -
Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
by: Mcgready, R, et al.
Published: (2006)